Myelodysplastic syndrome looks like a tough nut to crack and still remains a high unmet need. Here's a few drugs that have failed over recent years. Hopefully we have something that can help.
https://www.fiercebiotech.com/biotech/novartis-calls-time-tim-3-axing-cancer-candidate-after-phase-3-flop
https://www.biospace.com/aprea-therapeutics-crashes-with-phase-iii-flop-of-cancer-treatment
https://www.fiercebiotech.com/biotech/gilead-gives-49b-antibody-solid-tumor-plan-unravels
- Forums
- ASX - By Stock
- SNT
- Ann: German MDS group awarded $2.5m grant for phase 2 MDS trial
SNT
syntara limited
Add to My Watchlist
1.72%
!
5.7¢

Ann: German MDS group awarded $2.5m grant for phase 2 MDS trial, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $94.39M |
Open | High | Low | Value | Volume |
5.8¢ | 5.9¢ | 5.7¢ | $58.99K | 1.032M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 590004 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 760 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 590004 | 0.056 |
4 | 1365365 | 0.055 |
1 | 250000 | 0.054 |
1 | 100000 | 0.051 |
3 | 660000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 760 | 2 |
0.059 | 160185 | 1 |
0.061 | 87966 | 1 |
0.062 | 15000 | 1 |
0.063 | 82800 | 2 |
Last trade - 12.20pm 07/08/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |